Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 26:9:327.
doi: 10.3389/fpsyt.2018.00327. eCollection 2018.

Biological Predictors of Clozapine Response: A Systematic Review

Ruta Samanaite  1 , Amy Gillespie  1   2 , Kyra-Verena Sendt  1 , Grant McQueen  1 , James H MacCabe  1 , Alice Egerton  1
Affiliations

Biological Predictors of Clozapine Response: A Systematic Review

Ruta Samanaite et al. Front Psychiatry. .

Abstract

Background: Clozapine is the recommended antipsychotic for treatment-resistant schizophrenia (TRS) but there is significant variability between patients in the degree to which clozapine will improve symptoms. The biological basis of this variability is unknown. Although clozapine has efficacy in TRS, it can elicit adverse effects and initiation is often delayed. Identification of predictive biomarkers of clozapine response may aid initiation of clozapine treatment, as well as understanding of its mechanism of action. In this article we systematically review prospective or genetic studies of biological predictors of response to clozapine. Methods: We searched the PubMed database until 20th January 2018 for studies investigating "clozapine" AND ("response" OR "outcome") AND "schizophrenia." Inclusion required that studies examined a biological variable in relation to symptomatic response to clozapine. For all studies except genetic-studies, inclusion required that biological variables were measured before clozapine initiation. Results: Ninety-eight studies met the eligibility criteria and were included in the review, including neuroimaging, blood-based, cerebrospinal fluid (CSF)-based, and genetic predictors. The majority (70) are genetic studies, collectively investigating 379 different gene variants, however only three genetic variants (DRD3 Ser9Gly, HTR2A His452Tyr, and C825T GNB3) have independently replicated significant findings. Of the non-genetic variables, the most consistent predictors of a good response to clozapine are higher prefrontal cortical structural integrity and activity, and a lower ratio of the dopamine and serotonin metabolites, homovanillic acid (HVA): 5-hydroxyindoleacetic acid (5-HIAA) in CSF. Conclusions: Recommendations include that future studies should ensure adequate clozapine trial length and clozapine plasma concentrations, and may include multivariate models to increase predictive accuracy.

Keywords: clozapine; response biomarker; schizophrenia; treatment response; treatment-resistance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA diagram.
See this image and copyright information in PMC

References

    1. Meltzer HY. Treatment-resistant schizophrenia–the role of clozapine. Curr Med Res Opin. (1997) 14:1–20. 10.1185/03007999709113338 - DOI - PubMed
    1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry (1988) 45:789–96. 10.1001/archpsyc.1988.01800330013001 - DOI - PubMed
    1. Lewis SW, Barnes TRE, Davies L, Murray RM, Dunn G, Hayhurst KP, et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. (2006) 32:715–23. 10.1093/schbul/sbj067 - DOI - PMC - PubMed
    1. Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med. (1997) 337:809–15. 10.1056/NEJM199709183371202 - DOI - PubMed
    1. Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, et al. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. J Clin Psychiatry (2008) 69:274–85. 10.4088/JCP.v69n0214 - DOI - PubMed

LinkOut - more resources